Welcome to our dedicated page for Cartesian Growth Iii SEC filings (Ticker: CGCT), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Cartesian Growth Corporation III (NASDAQ: CGCT) files reports and transaction documents with the U.S. Securities and Exchange Commission that detail its activities as a special purpose acquisition company and its proposed Business Combination with Factorial Inc. Through this SEC filings page, readers can review current reports on Form 8-K, registration statements, and proxy materials that describe the structure, terms, and conditions of the transaction.
In a Form 8-K dated December 17, 2025, Cartesian III reported entry into a Business Combination Agreement with Factorial and a merger subsidiary. That filing outlines the planned domestication from the Cayman Islands to Delaware, the conversion of existing Cartesian III shares into New Factorial Series A Common Stock, the renaming of the post-closing entity to Factorial Holdings, Inc., and the subsequent merger in which Factorial becomes a wholly owned subsidiary. It also summarizes shareholder redemption rights, warrant treatment, governance arrangements, and key closing conditions, including Hart-Scott-Rodino clearance and Nasdaq listing approval.
On this page, users can access such 8-Ks along with other periodic and transactional filings to understand how CGCT’s units, Class A ordinary shares, and warrants are treated in the proposed combination. Filings also describe Cartesian III’s status as an emerging growth company and its affiliation with Cartesian Capital Group, LLC.
Stock Titan enhances access to these documents by pairing real-time updates from the SEC’s EDGAR system with AI-powered summaries that highlight the main points of lengthy agreements and disclosures. This helps readers quickly identify sections dealing with shareholder redemptions, exchange ratios, governance terms, and other elements that are central to evaluating Cartesian III’s Business Combination with Factorial.
Picton Mahoney Asset Management has filed an amended Schedule 13G reporting a significant ownership position in Cartesian Growth Corporation III. As of the event date of 12/31/2025, Picton Mahoney beneficially owned 1,400,000 Class A ordinary shares, with sole power to vote and dispose of all of these shares.
This stake represents 5.07% of the Class A ordinary shares, based on 27,600,000 Class A shares outstanding as of November 14, 2025, as referenced from the issuer’s Form 10-Q. Picton Mahoney is identified as a Canadian investment fund manager, and it certifies that it is subject to a foreign regulatory regime comparable to that of a functionally equivalent U.S. institution.
Cartesian Growth Corporation III and Factorial Inc. have signed a Business Combination Agreement dated December 17, 2025 to pursue a proposed business combination. The transaction will be put to a shareholder vote, and the parties plan to file a Form S-4 registration statement with the SEC that will include a proxy statement/prospectus for CGC shareholders and Factorial stockholders.
The communication highlights that the deal may include a private placement of common stock (a PIPE) and describes extensive forward-looking statements about Factorial’s early-stage solid-state battery business and the combined company. It stresses numerous risks, including deal completion, regulatory approvals, financing, technology development, competition, and broader economic and policy conditions. Investors are urged to read the future S-4, proxy statement/prospectus and related SEC filings carefully once available, and the text clarifies that this is not an offer to sell or a solicitation to buy securities.
Cartesian Growth Corporation III agreed to merge with Factorial Inc., a solid-state battery company, under a Business Combination Agreement that will take Factorial public through a SPAC transaction. The deal implies a fully diluted equity value of $1,100,000,000 for Factorial and is targeted to close in mid-2026, subject to shareholder approvals, regulatory clearance and other customary conditions.
Before closing, Cartesian will domesticate from the Cayman Islands to Delaware and be renamed Factorial Holdings, Inc., issuing Series A and Series B common stock. All Factorial shares, options and RSUs will convert into equity or awards linked to the new public company based on a defined exchange ratio.
The transaction is supported by a committed PIPE financing of $100,000,000, split between a Sponsor affiliate and an institutional investor, and includes new equity incentive and employee stock purchase plans that initially reserve 15% and 2% of fully diluted shares, respectively, with annual automatic increases after 2026.
Cartesian Growth Corporation III agreed to merge with solid-state battery developer Factorial Inc. in a SPAC business combination valuing Factorial at an implied fully diluted equity value of $1.1 billion. Before closing, CGC will domesticate from the Cayman Islands to Delaware and be renamed Factorial Holdings, Inc., with all existing CGC equity converting into new Series A common stock.
After the merger, Factorial will become a wholly owned subsidiary and its shareholders and founders will receive New Factorial common shares based on an exchange ratio tied to the $1.1 billion valuation. All Factorial options and RSUs will roll into new awards under a New Factorial equity plan.
The transaction is supported by a committed $100 million PIPE split between a sponsor affiliate and an institutional investor, and is targeted to close in mid-2026, subject to shareholder approvals, regulatory clearances, listing of the new shares on Nasdaq and other customary conditions. New long-term incentive and employee stock purchase plans, registration rights, warrant exchanges and staggered board and lock-up structures are also outlined.
Cartesian Growth Corporation III (CGCT) filed its Q3 2025 10-Q, reflecting SPAC-stage activity with interest income driving results. The company reported net income of $2,764,627 for the quarter, primarily from $2,901,973 of interest earned on investments in its Trust Account, offset by $137,346 in general and administrative costs.
Following its May 2025 IPO of 27,600,000 units at $10.00, the Trust Account held $280,669,717 as of September 30, 2025, invested in U.S. Treasury-focused mutual funds. Transaction costs totaled $18,821,468, including a $13,140,000 deferred underwriting fee. The company sold 6,800,000 private placement warrants for $6,800,000 and has 20,600,000 total warrants outstanding.
Cash was $660,638 outside the Trust, with operating cash use of $468,024 year-to-date. The company remains in its pre-combination phase and discloses substantial doubt about its ability to continue as a going concern absent a timely business combination within the stated completion window. As of November 14, 2025, shares outstanding were 27,600,000 Class A and 6,900,000 Class B.